4Filed Aug 13, 8:00 PM ET

LifeStance Health (LFST) Director Teresa DeLuca Sells 20,441 Shares

$LFST · LifeStance Health Group, Inc.

Research Summary

AI-generated summary of this SEC filing

Updated

LifeStance Health (LFST) Director Teresa DeLuca Sells 20,441 Shares

What Happened Teresa DeLuca, a director of LifeStance Health Group, Inc. (LFST), sold 20,441 shares in an open-market transaction on August 13, 2026. The shares were sold at $12.23 per share for total proceeds of $249,993. This was a sale (disposition) — sales are often routine and do not necessarily indicate a change in insider sentiment.

Key Details

  • Transaction date: 2026-08-13
  • Transaction type/code: Open market sale (S)
  • Price per share: $12.23
  • Shares sold: 20,441
  • Gross proceeds: $249,993
  • Shares owned after transaction: Not specified in the provided filing summary — see the Form 4 for post-transaction holdings.
  • Notes/footnotes: None provided in the summary supplied (no 10b5-1 plan, tax withholding, or other special instructions indicated).
  • Filing timeliness: Report filed 2026-08-14 for a transaction on 2026-08-13 — within the usual Form 4 reporting window (timely).

Context Insider sales are common and can reflect routine portfolio management, diversification, or liquidity needs; they are generally less informative than insider purchases for predicting future stock performance. No option exercises, gifts, or derivative transactions were reported in the supplied transaction details. For full context (total holdings, any footnotes, and issuer disclosures), consult the complete Form 4 filing (Accession No. 0001193125-26-352699).